<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font27 { font-size : 27; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font32">bone </span>
   <span class="font32">week </span>
   <span class="font30">mean </span>
   <span class="font29">baseline </span>
   <span class="font27">adults </span>
   <span class="font27">study </span>
   <span class="font27">subjects </span>
   <span class="font25">osteoid </span>
   <span class="font24">burosumab </span>
   <span class="font24">serum </span>
   <span class="font20">(%) </span>
   <span class="font20">(., </span>
   <span class="font20">mineralization </span>
   <span class="font20">{border-style </span>
   <span class="font20">osteomalacia </span>
   <span class="font20">therapy </span>
   <span class="font19">(.) </span>
   <span class="font19">conventional </span>
   <span class="font19">phosphorus </span>
   <span class="font19">px;} </span>
   <span class="font19">± . </span>
   <span class="font19">± .; </span>
   <span class="font19">#ffffff;} </span>
   <span class="font19">Bone </span>
   <span class="font19">histomorphometric </span>
   <span class="font18">XLH </span>
   <span class="font18">treatment </span>
   <span class="font18">X‐linked </span>
   <span class="font18">change </span>
   <span class="font17">lag </span>
   <span class="font16">phosphate </span>
   <span class="font16">surface/bone </span>
   <span class="font16">time </span>
   <span class="font15">Baseline </span>
   <span class="font15">biopsy </span>
   <span class="font15">decreased </span>
   <span class="font15">increase </span>
   <span class="font15">volume/bone </span>
   <span class="font15">fracture </span>
   <span class="font15">healing </span>
   <span class="font15">hypophosphatemia </span>
   <span class="font15">improvement </span>
   <span class="font15">pain </span>
   <span class="font15">phase </span>
   <span class="font14">CI, </span>
   <span class="font14">TEAE </span>
   <span class="font14">Week </span>
   <span class="font14">XLH, </span>
   <span class="font14">active </span>
   <span class="font14">children </span>
   <span class="font14">data </span>
   <span class="font14">experienced </span>
   <span class="font14">pseudofractures </span>
   <span class="font14">site </span>
   <span class="font14">subjects, </span>
   <span class="font14">trial </span>
   <span class="font14">Pain </span>
   <span class="font14">[], </span>
   <span class="font14">biopsies </span>
   <span class="font14">dose </span>
   <span class="font14">efficacy </span>
   <span class="font14">mean ± SE </span>
   <span class="font14">normal </span>
   <span class="font14">observed </span>
   <span class="font14">present </span>
   <span class="font14">px; </span>
   <span class="font14">surface, </span>
   <span class="font14">{font-family </span>
   <span class="font14"> weeks </span>
   <span class="font13">(Fig. </span>
   <span class="font13">.). </span>
   <span class="font13">AEs </span>
   <span class="font13">Burosumab </span>
   <span class="font13">Data </span>
   <span class="font13">Glorieux </span>
   <span class="font13">Inc. </span>
   <span class="font13">Mean </span>
   <span class="font13">Subjects </span>
   <span class="font13">Ultragenyx </span>
   <span class="font13">burosumab, </span>
   <span class="font13">changes </span>
   <span class="font13">cortical </span>
   <span class="font13">did </span>
   <span class="font13">font-size </span>
   <span class="font13">iliac </span>
   <span class="font13">including </span>
   <span class="font13">median </span>
   <span class="font13">parameters </span>
   <span class="font13">renal </span>
   <span class="font13">reported </span>
   <span class="font13">subject </span>
   <span class="font13">surface </span>
   <span class="font13">thickness </span>
   <span class="font13">using </span>
   <span class="font13">vitamin </span>
   <span class="font13">volume </span>
   <span class="font13">volume, </span>
   <span class="font13">Brief </span>
   <span class="font13">Department </span>
   <span class="font13">Insogna </span>
   <span class="font13">Miner </span>
   <span class="font13">Pharmaceutical </span>
   <span class="font13">Serum </span>
   <span class="font13">Sullivan </span>
   <span class="font13">University </span>
   <span class="font13">XLH. </span>
   <span class="font13">adverse </span>
   <span class="font13">calcium </span>
   <span class="font13">clinical </span>
   <span class="font13">colleagues </span>
   <span class="font13">current </span>
   <span class="font13">disease </span>
   <span class="font13">double; </span>
   <span class="font13">duration </span>
   <span class="font13">fractures </span>
   <span class="font13">improved </span>
   <span class="font13">increased </span>
   <span class="font13">increases </span>
   <span class="font13">markers </span>
   <span class="font13">quality </span>
   <span class="font13">rate. </span>
   <span class="font13">received </span>
   <span class="font13">reference </span>
   <span class="font13">respectively. </span>
   <span class="font13">rickets </span>
   <span class="font13">safety </span>
   <span class="font13">significantly </span>
   <span class="font13">skeletal </span>
   <span class="font13">standard </span>
   <span class="font13">study, </span>
   <span class="font13">tetracycline </span>
   <span class="font13">thickness, </span>
   <span class="font13">value </span>
   <span class="font13">values </span>
   <span class="font12">,(OH) </span>
   <span class="font12">Carpenter </span>
   <span class="font12">FGF </span>
   <span class="font12">Fatigue </span>
   <span class="font12">Figure </span>
   <span class="font12">Histomorphometric </span>
   <span class="font12">Hospital </span>
   <span class="font12">Osteomalacia </span>
   <span class="font12">Res. </span>
   <span class="font12">additional </span>
   <span class="font12">associated </span>
   <span class="font12">authors. </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">completed </span>
   <span class="font12">crest </span>
   <span class="font12">healing, </span>
   <span class="font12">healthy </span>
   <span class="font12">included </span>
   <span class="font12">interval </span>
   <span class="font12">levels </span>
   <span class="font12">maximum </span>
   <span class="font12">measures </span>
   <span class="font12">mid‐point </span>
   <span class="font12">number </span>
   <span class="font12">outcomes </span>
   <span class="font12">pain, </span>
   <span class="font12">percentage </span>
   <span class="font12">primary </span>
   <span class="font12">range </span>
   <span class="font12">score </span>
   <span class="font12">shown </span>
   <span class="font12">similar </span>
   <span class="font12">solid; </span>
   <span class="font12">treated </span>
   <span class="font12">treatment, </span>
   <span class="font12">use </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">± % </span>
   <span class="font12">± ; </span>
   <span class="font12">−. ± . </span>
   <span class="font12">(min, </span>
   <span class="font12">(two </span>
   <span class="font12">.%, </span>
   <span class="font12">Clin </span>
   <span class="font12">Imel </span>
   <span class="font12">Mineral </span>
   <span class="font12">Osteoid </span>
   <span class="font12">Study </span>
   <span class="font12">TmP/GFR </span>
   <span class="font12">USA </span>
   <span class="font12">Whyte </span>
   <span class="font12">adults. </span>
   <span class="font12">analysis, </span>
   <span class="font12">apposition </span>
   <span class="font12">assessed </span>
   <span class="font12">biochemical </span>
   <span class="font12">bold </span>
   <span class="font12">calculated </span>
   <span class="font12">considered </span>
   <span class="font12">courier; </span>
   <span class="font12">doses </span>
   <span class="font12">em; </span>
   <span class="font12">fasting </span>
   <span class="font12">fractures, </span>
   <span class="font12">healed </span>
   <span class="font12">hypophosphatemic </span>
   <span class="font12">identified </span>
   <span class="font12">impaired </span>
   <span class="font12">injection </span>
   <span class="font12">leading </span>
   <span class="font12">max) </span>
   <span class="font12">measured </span>
   <span class="font12">mild </span>
   <span class="font12">mineralizing </span>
   <span class="font12">moderate </span>
   <span class="font12">oral </span>
   <span class="font12">osteomalacia, </span>
   <span class="font12">osteomalacia. </span>
   <span class="font12">paired </span>
   <span class="font12">period </span>
   <span class="font12">procedure‐related </span>
   <span class="font12">profound </span>
   <span class="font12">pt;} </span>
   <span class="font12">randomized </span>
   <span class="font12">reabsorption </span>
   <span class="font12">reduction </span>
   <span class="font12">remodeling </span>
   <span class="font12">showed </span>
   <span class="font12">subjects), </span>
   <span class="font12">substantial </span>
   <span class="font12">therapeutic </span>
   <span class="font12">trabecular </span>
   <span class="font12">unmineralized </span>
   <span class="font12">weeks </span>
   <span class="font12"> weeks. </span>
   <span class="font12"> years </span>
   <span class="font12">−.; </span>
  </p>
 </body>
</html>
